Total Payments
$16,946
2024 Payments
$197.12
Companies
10
Transactions
64
Medicare Patients
349
Medicare Billing
$24,764
Payment Breakdown by Category
Consulting$7,150 (42.2%)
Travel$6,234 (36.8%)
Food & Beverage$2,762 (16.3%)
Research$741.49 (4.4%)
Other$58.00 (0.3%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $7,150 | 2 | 42.2% |
| Travel and Lodging | $6,234 | 20 | 36.8% |
| Food and Beverage | $2,762 | 36 | 16.3% |
| Unspecified | $741.49 | 5 | 4.4% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $58.00 | 1 | 0.3% |
Payments by Type
General
$16,204
59 transactions
Research
$741.49
5 transactions
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AbbVie Inc. | $5,249 | 18 | $0 (2023) |
| Lundbeck LLC | $4,870 | 7 | $0 (2017) |
| Acorda Therapeutics, Inc | $2,286 | 4 | $0 (2018) |
| Medtronic USA, Inc. | $2,060 | 16 | $0 (2017) |
| UCB, Inc. | $1,632 | 9 | $0 (2023) |
| ACADIA Pharmaceuticals Inc | $307.28 | 4 | $0 (2021) |
| Novocure Inc. | $277.58 | 3 | $0 (2024) |
| Abbott Laboratories | $111.36 | 1 | $0 (2017) |
| Theravance Biopharma Inc. | $88.00 | 1 | $0 (2017) |
| Stryker Corporation | $64.44 | 1 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $197.12 | 2 | Novocure Inc. ($132.68) |
| 2023 | $1,867 | 12 | UCB, Inc. ($1,632) |
| 2021 | $114.71 | 1 | ACADIA Pharmaceuticals Inc ($114.71) |
| 2020 | $112.14 | 1 | ACADIA Pharmaceuticals Inc ($112.14) |
| 2019 | $80.43 | 2 | ACADIA Pharmaceuticals Inc ($80.43) |
| 2018 | $4,475 | 13 | AbbVie, Inc. ($4,417) |
| 2017 | $10,099 | 33 | Lundbeck LLC ($4,870) |
All Payment Transactions
64 individual payment records from CMS Open Payments — Page 1 of 3
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 06/05/2024 | Stryker Corporation | MAKO (Device) | Food and Beverage | In-kind items and services | $64.44 | General |
| Category: KNEES, HIPS | ||||||
| 01/18/2024 | Novocure Inc. | Optune (Device) | Food and Beverage | Cash or cash equivalent | $132.68 | General |
| Category: Oncology | ||||||
| 12/01/2023 | AbbVie Inc. | — | Food and Beverage | In-kind items and services | $90.77 | General |
| 11/10/2023 | UCB, Inc. | — | Food and Beverage | Cash or cash equivalent | $69.66 | General |
| 11/10/2023 | UCB, Inc. | — | Travel and Lodging | Cash or cash equivalent | $13.10 | General |
| 10/27/2023 | UCB, Inc. | — | Travel and Lodging | In-kind items and services | $834.31 | General |
| 10/27/2023 | UCB, Inc. | — | Travel and Lodging | In-kind items and services | $252.70 | General |
| 10/27/2023 | UCB, Inc. | — | Travel and Lodging | In-kind items and services | $154.32 | General |
| 10/27/2023 | UCB, Inc. | — | Food and Beverage | In-kind items and services | $86.20 | General |
| 10/27/2023 | UCB, Inc. | — | Food and Beverage | In-kind items and services | $60.61 | General |
| 10/27/2023 | UCB, Inc. | — | Food and Beverage | In-kind items and services | $49.84 | General |
| 10/26/2023 | UCB, Inc. | — | Food and Beverage | In-kind items and services | $110.91 | General |
| 01/12/2023 | Novocure Inc. | Optune (Device) | Food and Beverage | Cash or cash equivalent | $134.90 | General |
| Category: Oncology | ||||||
| 01/12/2023 | Novocure Inc. | Optune (Device) | Travel and Lodging | Cash or cash equivalent | $10.00 | General |
| Category: Oncology | ||||||
| 08/18/2021 | ACADIA Pharmaceuticals Inc | NUPLAZID (Drug) | Food and Beverage | In-kind items and services | $114.71 | General |
| Category: PDP | ||||||
| 03/09/2020 | ACADIA Pharmaceuticals Inc | NUPLAZID (Drug) | Food and Beverage | In-kind items and services | $112.14 | General |
| Category: PARKINSONS DISEASE PSYCHOSIS | ||||||
| 04/18/2019 | ACADIA Pharmaceuticals Inc | NUPLAZID (Drug) | Food and Beverage | In-kind items and services | $38.76 | General |
| Category: PARKINSONS DISEASE PSYCHOSIS | ||||||
| 04/10/2019 | ACADIA Pharmaceuticals Inc | NUPLAZID (Drug) | Food and Beverage | In-kind items and services | $41.67 | General |
| Category: PARKINSONS DISEASE PSYCHOSIS | ||||||
| 09/18/2018 | AbbVie, Inc. | Duopa (Drug) | Consulting Fee | Cash or cash equivalent | $3,150.00 | General |
| Category: Neuroscience | ||||||
| 09/18/2018 | AbbVie, Inc. | Duopa (Drug) | Travel and Lodging | In-kind items and services | $84.48 | General |
| Category: Neuroscience | ||||||
| 09/18/2018 | AbbVie, Inc. | Duopa (Drug) | Travel and Lodging | In-kind items and services | $10.90 | General |
| Category: Neuroscience | ||||||
| 09/08/2018 | AbbVie, Inc. | Duopa (Drug) | Travel and Lodging | In-kind items and services | $677.92 | General |
| Category: Neuroscience | ||||||
| 09/08/2018 | AbbVie, Inc. | Duopa (Drug) | Travel and Lodging | In-kind items and services | $71.03 | General |
| Category: Neuroscience | ||||||
| 09/08/2018 | AbbVie, Inc. | Duopa (Drug) | Food and Beverage | In-kind items and services | $31.53 | General |
| Category: Neuroscience | ||||||
| 09/08/2018 | AbbVie, Inc. | Duopa (Drug) | Food and Beverage | In-kind items and services | $22.81 | General |
| Category: Neuroscience | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 2 | 42 | 45 | $13,219 | $3,564 |
| 2022 | 2 | 67 | 78 | $20,964 | $5,332 |
| 2021 | 4 | 133 | 143 | $36,669 | $9,079 |
| 2020 | 3 | 107 | 114 | $28,816 | $6,789 |
Total Patients
349
Total Services
380
Medicare Billing
$24,764
Procedure Codes
11
All Medicare Procedures & Services
11 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 24 | 27 | $6,075 | $1,833 | 30.2% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Facility | 2023 | 18 | 18 | $7,144 | $1,731 | 24.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2022 | 48 | 59 | $13,666 | $3,626 | 26.5% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Facility | 2022 | 19 | 19 | $7,298 | $1,706 | 23.4% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Facility | 2021 | 70 | 79 | $17,775 | $4,706 | 26.5% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Facility | 2021 | 35 | 35 | $13,125 | $3,001 | 22.9% |
| 99203 | New patient outpatient visit, total time 30-44 minutes | Facility | 2021 | 13 | 13 | $3,321 | $713.13 | 21.5% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Facility | 2021 | 15 | 16 | $2,448 | $657.81 | 26.9% |
| 99204 | New patient office or other outpatient visit, typically 45 minutes | Facility | 2020 | 34 | 34 | $12,544 | $3,096 | 24.7% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Facility | 2020 | 50 | 56 | $12,600 | $2,883 | 22.9% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Facility | 2020 | 23 | 24 | $3,672 | $810.16 | 22.1% |
About Dr. John Slevin, MD
Dr. John Slevin, MD is a Neurology healthcare provider based in Lexington, Kentucky. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/02/2006. The National Provider Identifier (NPI) number assigned to this provider is 1659319853.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. John Slevin, MD has received a total of $16,946 in payments from pharmaceutical and medical device companies, with $197.12 received in 2024. These payments were reported across 64 transactions from 10 companies. The most common payment nature is "Consulting Fee" ($7,150).
As a Medicare-enrolled provider, Slevin has provided services to 349 Medicare beneficiaries, totaling 380 services with total Medicare billing of $24,764. Data is available for 4 years (2020–2023), covering 11 distinct procedure/service records.
Ad
Practice Information
- Specialty Neurology
- Location Lexington, KY
- Active Since 06/02/2006
- Last Updated 04/27/2022
- Taxonomy Code 2084N0400X
- Entity Type Individual
- NPI Number 1659319853
Products in Payments
- NORTHERA (Drug) $4,845
- Duopa (Drug) $4,417
- ACTIVA (Device) $2,060
- NUPLAZID (Drug) $307.28
- Optune (Device) $277.58
- DBS IPGs (Device) $111.36
- MAKO (Device) $64.44
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Neurology Doctors in Lexington
Dr. Nicole Everman, M.d, M.D
Neurology — Payments: $506,986
Neurology $506,986
Toufic Fakhoury, Md, MD
Neurology — Payments: $393,864
Neurology $393,864
Larry Goldstein, Md, MD
Neurology — Payments: $28,134
Neurology $28,134
Jagannadha Avasarala, Md, Phd, MD, PHD
Neurology — Payments: $26,770
Neurology $26,770
Fred Odago, Md, MD
Neurology — Payments: $22,752
Neurology $22,752
Sharoon Qaiser, M.d, M.D
Neurology — Payments: $19,615
Neurology $19,615